Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311950034> ?p ?o ?g. }
- W4311950034 abstract "Abstract Background Although chemotherapy, the most widely used systemic treatment in triple‐negative breast cancer (TNBC), markedly improved the patients’ outcome, chemoresistance always occurs. This study purposed to explore new therapeutic strategies for the treatment of chemoresistance. Methods and results The expression and prognostic value of DAB2IP were investigated in TNBC tissues and cell lines. Low DAB2IP expression predicted high mortality risk in TNBC. Inhibition of DAB2IP expression conferred cancer stem cell capacity and chemoresistance in TNBC cell lines. Using murine breast cancer (BC) xenograft models, we evaluated the association with DAB2IP and chemoresistance. DAB2IP inhibited TNBC tumourigenesis and chemoresistance in vivo. Further, we revealed that DAB2IP inhibited β‐catenin nuclear transport through competitive interaction with RAC1 and decreased β‐catenin accumulation in the cell nucleus. Finally, we found that the DNA methylation level was negatively associated with DAB2IP expression in TNBC. Inhibition of DNA methylation restored the DAB2IP expression and attenuated chemoresistance in TNBC. Conclusions We revealed that DAB2IP attenuates chemoresistance of TNBC via inhibition of RAC1‐mediated β‐catenin nuclear accumulation. Decitabine treatment results in re‐expression of DAB2IP by inhibiting DNA methylation and could be a potential therapeutic strategy for chemoresistance in TNBC." @default.
- W4311950034 created "2023-01-03" @default.
- W4311950034 creator A5003421579 @default.
- W4311950034 creator A5008343909 @default.
- W4311950034 creator A5011715383 @default.
- W4311950034 creator A5015287299 @default.
- W4311950034 creator A5016218825 @default.
- W4311950034 creator A5018814025 @default.
- W4311950034 creator A5059349758 @default.
- W4311950034 creator A5066943445 @default.
- W4311950034 date "2022-12-01" @default.
- W4311950034 modified "2023-10-01" @default.
- W4311950034 title "DAB2IP attenuates chemoresistance of triple‐negative breast cancer through sequestration of RAC1 to prevent β‐catenin nuclear accumulation" @default.
- W4311950034 cites W1518932181 @default.
- W4311950034 cites W1971026364 @default.
- W4311950034 cites W1987557775 @default.
- W4311950034 cites W1994423181 @default.
- W4311950034 cites W2001992345 @default.
- W4311950034 cites W2003569663 @default.
- W4311950034 cites W2012117840 @default.
- W4311950034 cites W2018372624 @default.
- W4311950034 cites W2018440411 @default.
- W4311950034 cites W2042619042 @default.
- W4311950034 cites W2050300062 @default.
- W4311950034 cites W2076808589 @default.
- W4311950034 cites W2096027508 @default.
- W4311950034 cites W2097802504 @default.
- W4311950034 cites W2107277218 @default.
- W4311950034 cites W2108244474 @default.
- W4311950034 cites W2118605519 @default.
- W4311950034 cites W2130330090 @default.
- W4311950034 cites W2131596261 @default.
- W4311950034 cites W2135925682 @default.
- W4311950034 cites W2139122477 @default.
- W4311950034 cites W2142742974 @default.
- W4311950034 cites W2144027697 @default.
- W4311950034 cites W2147516356 @default.
- W4311950034 cites W2189546716 @default.
- W4311950034 cites W2192080449 @default.
- W4311950034 cites W2415103409 @default.
- W4311950034 cites W2474707695 @default.
- W4311950034 cites W2519953954 @default.
- W4311950034 cites W2536094308 @default.
- W4311950034 cites W2556270292 @default.
- W4311950034 cites W2564435391 @default.
- W4311950034 cites W2564847411 @default.
- W4311950034 cites W2763367287 @default.
- W4311950034 cites W2800852522 @default.
- W4311950034 cites W2802638385 @default.
- W4311950034 cites W2806209829 @default.
- W4311950034 cites W2891589486 @default.
- W4311950034 cites W2911718257 @default.
- W4311950034 cites W2912993657 @default.
- W4311950034 cites W2965386709 @default.
- W4311950034 cites W2965561098 @default.
- W4311950034 cites W3026114757 @default.
- W4311950034 cites W3069004765 @default.
- W4311950034 cites W3087640434 @default.
- W4311950034 cites W3093053585 @default.
- W4311950034 cites W3108389912 @default.
- W4311950034 cites W3120729122 @default.
- W4311950034 cites W3198051187 @default.
- W4311950034 cites W4206390491 @default.
- W4311950034 cites W4304687446 @default.
- W4311950034 cites W4311950034 @default.
- W4311950034 doi "https://doi.org/10.1002/ctm2.1133" @default.
- W4311950034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36536485" @default.
- W4311950034 hasPublicationYear "2022" @default.
- W4311950034 type Work @default.
- W4311950034 citedByCount "5" @default.
- W4311950034 countsByYear W43119500342022 @default.
- W4311950034 countsByYear W43119500342023 @default.
- W4311950034 crossrefType "journal-article" @default.
- W4311950034 hasAuthorship W4311950034A5003421579 @default.
- W4311950034 hasAuthorship W4311950034A5008343909 @default.
- W4311950034 hasAuthorship W4311950034A5011715383 @default.
- W4311950034 hasAuthorship W4311950034A5015287299 @default.
- W4311950034 hasAuthorship W4311950034A5016218825 @default.
- W4311950034 hasAuthorship W4311950034A5018814025 @default.
- W4311950034 hasAuthorship W4311950034A5059349758 @default.
- W4311950034 hasAuthorship W4311950034A5066943445 @default.
- W4311950034 hasBestOaLocation W43119500341 @default.
- W4311950034 hasConcept C104317684 @default.
- W4311950034 hasConcept C121608353 @default.
- W4311950034 hasConcept C126322002 @default.
- W4311950034 hasConcept C137620995 @default.
- W4311950034 hasConcept C150194340 @default.
- W4311950034 hasConcept C185592680 @default.
- W4311950034 hasConcept C190727270 @default.
- W4311950034 hasConcept C2779717556 @default.
- W4311950034 hasConcept C2780110267 @default.
- W4311950034 hasConcept C30145163 @default.
- W4311950034 hasConcept C33288867 @default.
- W4311950034 hasConcept C502942594 @default.
- W4311950034 hasConcept C530470458 @default.
- W4311950034 hasConcept C552990157 @default.
- W4311950034 hasConcept C55493867 @default.
- W4311950034 hasConcept C62478195 @default.
- W4311950034 hasConcept C71924100 @default.
- W4311950034 hasConcept C86803240 @default.